# HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

> **NCT05354778** · NA · RECRUITING · sponsor: **Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo** · enrollment: 180 (estimated)

## Conditions studied

- Healthcare-Associated Pneumonia
- Ventilator Associated Pneumonia

## Interventions

- **DRUG:** Hydrocortisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05354778
- **Lead sponsor:** Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-16
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354778, "HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05354778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*